Dolby Laboratories (NYSE:DLB) Cut to “Hold” at Wall Street Zen

Dolby Laboratories (NYSE:DLB) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

A number of other equities research analysts also recently commented on DLB. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Friday. Barrington Research decreased their target price on Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research report on Monday, January 26th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Monday, December 29th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Dolby Laboratories Trading Up 1.8%

Shares of NYSE DLB opened at $64.19 on Friday. Dolby Laboratories has a 1-year low of $60.14 and a 1-year high of $85.49. The company has a 50-day moving average of $65.07 and a two-hundred day moving average of $68.88. The company has a market cap of $6.13 billion, a PE ratio of 25.88 and a beta of 0.88.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Thursday, January 29th. The electronics maker reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.99 by $0.07. The company had revenue of $346.71 million during the quarter, compared to the consensus estimate of $341.26 million. Dolby Laboratories had a return on equity of 11.49% and a net margin of 17.97%.The firm’s quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.14 earnings per share. As a group, equities research analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current year.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 2,491 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $67.26, for a total transaction of $167,544.66. Following the transaction, the executive vice president owned 70,563 shares of the company’s stock, valued at $4,746,067.38. The trade was a 3.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP John D. Couling sold 7,273 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $68.75, for a total transaction of $500,018.75. Following the transaction, the senior vice president owned 108,065 shares in the company, valued at approximately $7,429,468.75. The trade was a 6.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 137,120 shares of company stock worth $9,184,809. Company insiders own 37.93% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Boothbay Fund Management LLC boosted its position in shares of Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 157 shares during the period. Mitchell & Pahl Private Wealth LLC raised its stake in Dolby Laboratories by 1.1% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock worth $1,139,000 after purchasing an additional 170 shares in the last quarter. Equitable Trust Co. raised its stake in Dolby Laboratories by 3.3% in the 2nd quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock worth $413,000 after purchasing an additional 177 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its holdings in Dolby Laboratories by 13.9% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker’s stock valued at $118,000 after purchasing an additional 194 shares during the period. Finally, State of Michigan Retirement System grew its position in shares of Dolby Laboratories by 1.4% during the 2nd quarter. State of Michigan Retirement System now owns 14,800 shares of the electronics maker’s stock worth $1,099,000 after purchasing an additional 200 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories News Roundup

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Company raised FY‑2026 and Q2 guidance well above Street estimates (FY EPS 4.30–4.45 vs. consensus ~3.79; Q2 EPS 1.29–1.44). The stronger outlook is the main catalyst supporting the stock today.
• Positive Sentiment: Dolby announced a quarterly dividend of $0.36 per share (yield ~2.3%), which can attract income-oriented investors and support the share price around the ex‑dividend date.
• Positive Sentiment: Rosenblatt reaffirmed a “Buy” rating with an $85 price target, adding analyst support and upside narrative for investors. Benzinga
• Neutral Sentiment: Q1 results beat consensus on EPS ($1.06 vs. ~$0.99) and revenue (~$346.7M vs. ~341M), indicating operational resilience even as some metrics softened. PR Newswire
• Negative Sentiment: Revenue and EPS were down year-over-year (revenue down ~2.8%), driven by weaker licensing, which triggered an after‑hours selloff after the print and remains a near-term risk. Zacks
• Negative Sentiment: Operational and cash-flow pressures were noted (operating profit and net income declined; temporary negative operating cash flow and higher capex flagged by third‑party summaries), which could weigh on near‑term margins and investor sentiment. Quiver Quant

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.